Compare WWD & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WWD | EXAS |
|---|---|---|
| Founded | 1870 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8B | 19.3B |
| IPO Year | N/A | N/A |
| Metric | WWD | EXAS |
|---|---|---|
| Price | $332.32 | $102.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 20 |
| Target Price | ★ $298.18 | $80.25 |
| AVG Volume (30 Days) | 530.4K | ★ 2.4M |
| Earning Date | 02-02-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | ★ 19.63 | N/A |
| EPS | ★ 7.19 | N/A |
| Revenue | ★ $3,567,064,000.00 | $3,082,033,000.00 |
| Revenue This Year | $12.28 | $19.40 |
| Revenue Next Year | $8.54 | $13.51 |
| P/E Ratio | $46.73 | ★ N/A |
| Revenue Growth | 7.30 | ★ 14.47 |
| 52 Week Low | $146.82 | $38.81 |
| 52 Week High | $338.17 | $102.66 |
| Indicator | WWD | EXAS |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 84.47 |
| Support Level | $321.99 | $101.51 |
| Resistance Level | $338.17 | $102.56 |
| Average True Range (ATR) | 7.88 | 0.34 |
| MACD | 0.77 | -0.65 |
| Stochastic Oscillator | 83.27 | 85.71 |
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.